Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. 1994

Y Imai, and A Fusco, and Y Suzuki, and M A Lesniak, and R D'Alfonso, and G Sesti, and A Bertoli, and R Lauro, and D Accili, and S I Taylor
Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland 20892.

The pathophysiology of noninsulin-dependent diabetes mellitus (NIDDM) is characterized by insulin resistance and insulin deficiency. To search for genetic defects causing NIDDM, we have screened for mutations in the gene encoding insulin receptor substrate-1 (IRS-1), an intracellular protein that is phosphorylated by the insulin receptor and is thought to play an important role in mediating insulin action. The coding sequence of the IRS-1 gene (divided into 12 overlapping fragments) was amplified by polymerase chain reaction and screened for the presence of single stranded conformational polymorphisms. This led to the identification of 6 variants in the nucleotide sequence. There were 3 nonconservative amino acids substitutions: Gly819-->Arg, Gly972-->Arg, and Arg1221-->Cys. In addition, there were three silent polymorphisms: GAC vs. GAT encoding Asp90, GGG vs. GGA encoding Gly235, and GCA vs. GCG encoding Ala805. The previously reported Arg972 substitution was identified in 7 of 31 patients with NIDDM, 4 of 32 normal subjects, and 4 of 16 nondiabetic obese individuals. The 2 novel amino acid substitutions (Arg819 and Cys1221) were both detected in 1 patient with NIDDM, but not in either of the other 2 groups of nondiabetic individuals. All 3 amino acid residues are identically conserved in the amino acid sequences of human, mouse, and rat IRS-1, suggesting that Gly819, Gly972, and Arg1221 are important for the normal function of IRS-1. Furthermore, the prevalence of amino acid substitutions in IRS-1 is increased in patients with NIDDM. These observations suggest that mutations in the IRS-1 gene may play a causal role in the pathogenesis of NIDDM.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010750 Phosphoproteins Phosphoprotein
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Imai, and A Fusco, and Y Suzuki, and M A Lesniak, and R D'Alfonso, and G Sesti, and A Bertoli, and R Lauro, and D Accili, and S I Taylor
December 1997, The Journal of clinical endocrinology and metabolism,
Y Imai, and A Fusco, and Y Suzuki, and M A Lesniak, and R D'Alfonso, and G Sesti, and A Bertoli, and R Lauro, and D Accili, and S I Taylor
February 1996, Diabetic medicine : a journal of the British Diabetic Association,
Y Imai, and A Fusco, and Y Suzuki, and M A Lesniak, and R D'Alfonso, and G Sesti, and A Bertoli, and R Lauro, and D Accili, and S I Taylor
September 1998, Zhonghua yi xue za zhi,
Y Imai, and A Fusco, and Y Suzuki, and M A Lesniak, and R D'Alfonso, and G Sesti, and A Bertoli, and R Lauro, and D Accili, and S I Taylor
September 1995, The Journal of clinical endocrinology and metabolism,
Y Imai, and A Fusco, and Y Suzuki, and M A Lesniak, and R D'Alfonso, and G Sesti, and A Bertoli, and R Lauro, and D Accili, and S I Taylor
January 1996, Human mutation,
Y Imai, and A Fusco, and Y Suzuki, and M A Lesniak, and R D'Alfonso, and G Sesti, and A Bertoli, and R Lauro, and D Accili, and S I Taylor
April 1996, The Journal of clinical endocrinology and metabolism,
Y Imai, and A Fusco, and Y Suzuki, and M A Lesniak, and R D'Alfonso, and G Sesti, and A Bertoli, and R Lauro, and D Accili, and S I Taylor
July 1985, The Journal of clinical endocrinology and metabolism,
Y Imai, and A Fusco, and Y Suzuki, and M A Lesniak, and R D'Alfonso, and G Sesti, and A Bertoli, and R Lauro, and D Accili, and S I Taylor
August 1993, The Journal of clinical endocrinology and metabolism,
Y Imai, and A Fusco, and Y Suzuki, and M A Lesniak, and R D'Alfonso, and G Sesti, and A Bertoli, and R Lauro, and D Accili, and S I Taylor
December 2014, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Y Imai, and A Fusco, and Y Suzuki, and M A Lesniak, and R D'Alfonso, and G Sesti, and A Bertoli, and R Lauro, and D Accili, and S I Taylor
January 2000, Chinese medical journal,
Copied contents to your clipboard!